Miriam O’Leary, MD, is a board-certified otolaryngologist (ENT) and Chair of Otolaryngology at Tufts Medical Center. Dr. O’Leary is also an associate professor at Tufts University School of Medicine.

Poor oral health isn’t just a dental concern. Research shows gum disease can trigger inflammation that raises stroke risk, making daily oral care essential for protecting both brain and overall health ...

Wondering if bad breath or bleeding gums mean you need a deep teeth cleaning? Discover what these signs could be warning you ...

Marine viruses deploy a sophisticated Trojan horse maneuver that enables them to dismantle the energy systems of ocean bacteria and use the breakdown products for self-replication. This finding comes ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Coughing—especially these days with COVID and who knows what else flying around—will earn you the ...

Bacteria-killing viruses built from scratch in a University of Pittsburgh lab could be a breakthrough in the battle against fearsome antibiotic-resistant infections. Pitt biotechnology researcher ...

It’s a home cook’s nightmare: You open the fridge ready to make dinner and realize the meat has spoiled. You have to throw it out, kicking yourself for not cooking it sooner. According to the USDA, a ...

Penn State scientists uncovered an ancient bacterial defense where dormant viral DNA helps bacteria fight new viral threats. The enzyme PinQ flips bacterial genes to create protective proteins that ...

For billions of years, bacteria and viruses have engaged in constant battles. We generally think of bacteria as bad, but viruses as worse. The truth is more nuanced: some bacteria have ancient viruses ...

Every year, around 600 million people are struck down by foodborne illnesses. The culprits are often common yet dangerous bacteria, such as E. coli and Salmonella, that thrive in undercooked or ...

Oct 31 (Reuters) - Tiny viruses that only infect and kill bacteria can help treat deadly antibiotic-resistant bloodstream infections with Staphylococcus aureus, results from a mid-stage trial suggest.